EP1345581A2 - Zinc containing dentifrice of reduced astringency - Google Patents

Zinc containing dentifrice of reduced astringency

Info

Publication number
EP1345581A2
EP1345581A2 EP01992031A EP01992031A EP1345581A2 EP 1345581 A2 EP1345581 A2 EP 1345581A2 EP 01992031 A EP01992031 A EP 01992031A EP 01992031 A EP01992031 A EP 01992031A EP 1345581 A2 EP1345581 A2 EP 1345581A2
Authority
EP
European Patent Office
Prior art keywords
composition
zinc
pyrophosphate
salt
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01992031A
Other languages
German (de)
French (fr)
Inventor
Diego A. Hoic
Michael Prencipe
Bernie Blackwell
James R. Brown
Mahmoud Hassan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of EP1345581A2 publication Critical patent/EP1345581A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention relates to a dentifrice composition useful for reducing oral malodor and more particularly a low astringent breath freshening oral care product for the treatment of oral malodor containing a combination of zinc and pyrophosphate salts.
  • Oral malodor, or halitosis is caused by the putrefactive activity of microorganisms on appropriate substrate components of dental plaque, debris adhering to mucous membranes and salivary cellular elements to produce volatile sulfur compounds primarily hydrogen sulfide, methyl mercaptan and traces of methyl sulfide.
  • US 4,138,477 discloses a zinc salt containing oral composition of reduced astringency wherein the composition contains a zinc-polymer complex formed by the reaction of a zinc salt with an anionic polymer containing carboxylic, sulfonic and/or phosphonic acid radicals.
  • US 5,000,944 discloses a zinc containing antitartar oral product substantially free of astringency, containing as the essential agent, a zinc/polyphosphate complex having at least about a 50% water solubility, formed by reaction of a zinc salt with a potassium or sodium polyphosphate salt by dissolving a zinc salt in a polyphosphate solution such as pyrophosphate, tripolyphosphate, hexametaphosphate and combinations thereof.
  • a zinc/polyphosphate complex having at least about a 50% water solubility, formed by reaction of a zinc salt with a potassium or sodium polyphosphate salt by dissolving a zinc salt in a polyphosphate solution such as pyrophosphate, tripolyphosphate, hexametaphosphate and combinations thereof.
  • a drawback to zinc/polyphosphate complex salts is that although astringency is substantially reduced, dentifrices containing zinc and polyphosphate salts have a propensity towards instability, wherein during storage, polycrystalline lumps form, such formation being believed to be caused by the aggregation of crystals of the zinc- polyphosphate complex. These lumps are visible to the naked eye, have a substantial hardness so that the spontaneous formation of these zinc/polyphosphate crystals are highly undesirable and detrimental to consumer acceptance of the dental product. Therefore, there is a need in the art for a means whereby both the stability and astringency characteristics of oral care products containing zinc salts can be improved so that such products will be more acceptable for use by consumers.
  • a stable aqueous oral care composition for the treatment of oral malodor having limited astringency comprising an orally acceptable vehicle containing a complex formed from zinc salt, anionic polycarboxylate polymer and a pyrophosphate salt ingredients incorporated in to the oral care composition.
  • the presence of the zinc anionic polycarboxylate polymer pyrophosphate complex in the oral care product unexpectedly provides a stable product of substantially reduced astringency having improved palatability when used by the consumer.
  • the source of zinc ion used to form the zinc/anionic polycarboxylate polymer/pyrophosphate complex in the oral care composition is generally a zinc salt that is fully or partially soluble in water, including zinc nitrate, zinc sulfate, zinc citrate, zinc chloride, zinc citrate being preferred.
  • the zinc salt is generally incorporated in the oral care composition of the present invention at a concentration of about 1 to about 5% by weight and preferably about 1.5 to about 3% by weight.
  • Anionic polycarboxylate polymers used to form the zinc/anionic polycarboxylate polymer/pyrophosphate complex are generally employed in the form of their free acids or preferably partially or fully neutralized water soluble alkali metal (e.g., potassium and preferably sodium) or ammonium salts.
  • Preferred are 1 :4 to 4:1 copolymers of maleic anhydride or acid with another polmerizable ethylenically unsaturated monomer, preferably methylvinylether/maleic anhydride having a molecular weight (M.W.) of about 30,000 to about 1,800,000 most preferably about 30,000 to about 700,000.
  • copolymers examples are available from ISP Corporation under the tradename Gantrez, e.g., AN 139 (M.W. 500,000), AN 119 (M.W. 250,000); S-97 Pharmaceutical Grade (M.W. 700,000), AN 169 (M.W. 1,200,000-1800,000), and AN 179 (M.W. above 1,800,000); wherein the preferred copolymer is S-97 Pharmaceutical Grade (M.W. 700,000).
  • Gantrez e.g., AN 139 (M.W. 500,000), AN 119 (M.W. 250,000); S-97 Pharmaceutical Grade (M.W. 700,000), AN 169 (M.W. 1,200,000-1800,000), and AN 179 (M.W. above 1,800,000); wherein the preferred copolymer is S-97 Pharmaceutical Grade (M.W. 700,000).
  • the anionic polycarboxylate polymer is employed in amounts effective to form the zinc-polymer-pyrophosphate complex within the oral composition.
  • the anionic polycarboxylate polymer is incorporated in the oral care composition from about 0.1% to about 10% by weight, preferably from about 0.2% to about 3.0% by weight.
  • Pyrophosphate salts used to prepare the zinc/anionic polymer/pyrophosphate complexes include dialkali or tetraalkali metal pyrophosphate salts such as Na 2 P 2 O 7 ,
  • the pyrophosphate salts are included in the oral composition of the present invention at a concentration of about 1 to about 5% by weight and preferably about 0.5 to about 3% by weight.
  • the zinc salt anionic polycarboxylate polymer and pyrophosphate salt ingredients are incorporated in the oral care product which includes a vehicle which contains water, humectant, surfactant and a polishing agent.
  • the humectant is generally a mixture of humectants, such as glycerol, sorbitol and polyethylene glycol of molecular weight in the range of 200-1000, but other mixtures of humectants and single humectants may also be employed.
  • the humectant content is in the range about of 10% to about 80% by weight and preferably about 30 to about 50% by weight.
  • the water content is in the range of about 10 to about 25% by weight.
  • Inorganic thickeners may be included in the dentifrice component in which potassium salts are included as an ingredient include fumed silicas such as Cabosil available from Cabot Corporation, and thickening silicas including those available from Crosfield Chemicals designated Sorbosil TC-15 or Sylox 15 from W.R. Grace.
  • fumed silicas such as Cabosil available from Cabot Corporation
  • thickening silicas including those available from Crosfield Chemicals designated Sorbosil TC-15 or Sylox 15 from W.R. Grace.
  • Organic thickeners of natural and synthetic gums may be incorporated in the oral care composition of the present invention.
  • examples of such thickeners are carrageenan (Irish moss), xanthan gum, sodium carboxymethyl cellulose, starch, polyvinylpyrrolidone, hydroxyethylpropylcellulose,hydroxybutyl methyl cellulose, hydroxypropyl methyl cellulose, and hydroxyethyl cellulose.
  • the organic thickener may be incorporated in the compositions of the present invention at a concentration of about 0.25 to about 2% by weight and preferably about 0.5 to about 1% by weight.
  • Surfactants may be incorporated in the oral care product of the present invention included as an ingredient to provide foaming properties.
  • the surfactant is preferably anionic, suitable examples of which include higher alkyl sulfates such as potassium or sodium lauryl sulfate which is preferred, higher fatty acid monoglyceride monosulfates, such as the salt of the monosulfated monoglyceride of hydrogenated coconut oil fatty acids, alkyl aryl sulfonates such as sodium dodecyl benzene sulfonate, higher fatty sulfoacetates, higher fatty acid esters of 1,2 dihydroxy propane sulfonate, and the substantially saturated higher aliphatic acyl amides of lower aliphatic amino carboxylic acid compounds, such as those having 12 to 16 carbons in the fatty acid, alkyl or acyl radicals, and the like.
  • amides are N-lauroyl sarcosine, and the salts of N-lauroyl, N-myristoyl, or N-palmitoyl sarcosine.
  • the surfactant is generally present in the oral care compositions of the present invention at a concentration of about 0.5 to about 5.0% by weight.
  • Abrasives may be incorporated in the oral composition of the present invention and preferred abrasives are siliceous materials, such as silica.
  • a preferred silica is a precipitated amorphous hydrated silica, such as Sorbosil AC-35, marketed by Crosfield Chemicals, or Zeodent 115 and Zeodent 165 from Huber Company but other abrasives may also be employed, including sodium metaphosphate, potassium metaphosphate, tricalcium phosphate, calcium phosphate dihydrate, anhydrous dicalcium phosphate, calcium pyrophosphate, magnesium orthophosphate, calcium carbonate, sodium bicarbonate, alumina trihydrate, aluminum silicate, calcined alumina and bentonite.
  • the concentration of abrasive in the oral composition of the present invention will normally be in the range of 5 to about 40% by weight and preferably 10 to 30% by weight.
  • ingredients which may be incorporated in the oral care composition of the present invention include pigment, sweetener, flavor and preservative.
  • the pigment of choice is titanium dioxide, rutile, and the proportion thereof will normally be in the range of 0.5 to 1.25% by weight, preferably 0.75 to 1 % by weight.
  • the sweetener content will normally be that of an artificial or synthetic sweetener and the normal proportion thereof present will be in the range of 0.1 to 1% by weight, preferably 0.3 to 0.5% by weight.
  • the flavor content which is preferably of a mixed peppermint/menthol flavor, will usually be in the range of 0.5 to 2% by weight, preferably 0.5 to 1.5% by weight.
  • F.D the pigment of choice is titanium dioxide, rutile, and the proportion thereof will normally be in the range of 0.5 to 1.25% by weight, preferably 0.75 to 1 % by weight.
  • the sweetener content will normally be that of an artificial or synthetic sweetener and the normal proportion thereof present will be in the range of 0.1 to 1% by weight
  • the contents of other components or adjuvants of the potassium salt containing dentifrice will normally not exceed 10% by weight, often will be less than 5% by weight, and can be as low as 0%.
  • the zinc salt is added to a mixture of water, humectants and anionic polycarboxylate polymer and dispersed in a conventional mixer until the mixture becomes a slurry which is smooth in appearance.
  • the pyrophosphate salt may also be added at this point, preferably predissolved as a water solution.
  • Other water soluble ingredients such as fluoride salts and sweeteners such as sodium saccharin may also be added at this point.
  • This mixture may be heated to 100-110°F and mixed for 10 to 30 minutes producing a homogeneous gel phase. The mixture is transferred to a vacuum mixer.
  • the abrasive is then added and mixed for 10 to 30 minutes at high speed under a vacuum in the range of 5 to 100 millimeter of mercury pressure, preferably 5 to 50 mm Hg, providing a homogenous mixture.
  • the surfactant and flavor are then added to the paste which is followed by mixing another 10 to 20 minutes under vacuum of 5 to 50 mm Hg.
  • the resultant product is a stable astringent dentifrice of a texture like that of normal toothpastes or gels having a pH in the range of 5 to 8, preferably 6.5 to 7.5, e.g., 7, and of satisfactory flavor.
  • the astringency and palatability of the dentifrice was evaluated by a flavorist for attributes such as astringency and taste acceptability as compared to a commercial non- astringent antibacterial dentifrice which did not contain zinc ion and a commercial dentifrice known to be astringent containing 2% by weight zinc citrate.
  • the flavorist rated the dentifrice as having minor astringency.
  • the dentifrice of the Example was prepared in which the zinc citrate was incorporated in the dentifrice composition together with 1% by weight tetrasodium pyrophosphate and 7% by weight of sodium tripolyphosphate and the anionic polycarboxylate polymer Gantrez S-97 was not included in the dentifrice composition, the composition had low astringency but undesirable crystals formed in the dentifrice within 15 days when stored in plastic tubes at room temperature.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

A stable, zinc containing aqueous oral composition having low astringency, the composition containing a mixture of a zinc salt, an anionic polycarboxylate polymer and a pyrophosphate salt whereby less astringency is experienced by the user of the composition.

Description

ZINC CONTAINING DENTIFRICE OF REDUCED ASTRINGENCY
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a dentifrice composition useful for reducing oral malodor and more particularly a low astringent breath freshening oral care product for the treatment of oral malodor containing a combination of zinc and pyrophosphate salts.
Oral malodor, or halitosis, is caused by the putrefactive activity of microorganisms on appropriate substrate components of dental plaque, debris adhering to mucous membranes and salivary cellular elements to produce volatile sulfur compounds primarily hydrogen sulfide, methyl mercaptan and traces of methyl sulfide.
The incorporation of zinc salts into oral dental care products to beneficially reduce oral malodor is well known in the art, as for example, US Pat. Nos. 4,138,477 and 5,000,944. However, the astringency of zinc salts is a major drawback in its use in oral dental care products creating an unpleasant astringent taste in the mouth.
US 4,138,477 discloses a zinc salt containing oral composition of reduced astringency wherein the composition contains a zinc-polymer complex formed by the reaction of a zinc salt with an anionic polymer containing carboxylic, sulfonic and/or phosphonic acid radicals.
US 5,000,944 discloses a zinc containing antitartar oral product substantially free of astringency, containing as the essential agent, a zinc/polyphosphate complex having at least about a 50% water solubility, formed by reaction of a zinc salt with a potassium or sodium polyphosphate salt by dissolving a zinc salt in a polyphosphate solution such as pyrophosphate, tripolyphosphate, hexametaphosphate and combinations thereof. A drawback to zinc/polyphosphate complex salts is that although astringency is substantially reduced, dentifrices containing zinc and polyphosphate salts have a propensity towards instability, wherein during storage, polycrystalline lumps form, such formation being believed to be caused by the aggregation of crystals of the zinc- polyphosphate complex. These lumps are visible to the naked eye, have a substantial hardness so that the spontaneous formation of these zinc/polyphosphate crystals are highly undesirable and detrimental to consumer acceptance of the dental product. Therefore, there is a need in the art for a means whereby both the stability and astringency characteristics of oral care products containing zinc salts can be improved so that such products will be more acceptable for use by consumers.
SUMMARY OF THE INVENTION
In accordance with the present invention there is provided a stable aqueous oral care composition for the treatment of oral malodor having limited astringency, the composition comprising an orally acceptable vehicle containing a complex formed from zinc salt, anionic polycarboxylate polymer and a pyrophosphate salt ingredients incorporated in to the oral care composition.
As will hereinafter be demonstrated, the presence of the zinc anionic polycarboxylate polymer pyrophosphate complex in the oral care product unexpectedly provides a stable product of substantially reduced astringency having improved palatability when used by the consumer.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
In the practice of the present invention, the source of zinc ion used to form the zinc/anionic polycarboxylate polymer/pyrophosphate complex in the oral care composition is generally a zinc salt that is fully or partially soluble in water, including zinc nitrate, zinc sulfate, zinc citrate, zinc chloride, zinc citrate being preferred. The zinc salt is generally incorporated in the oral care composition of the present invention at a concentration of about 1 to about 5% by weight and preferably about 1.5 to about 3% by weight. Anionic polycarboxylate polymers used to form the zinc/anionic polycarboxylate polymer/pyrophosphate complex are generally employed in the form of their free acids or preferably partially or fully neutralized water soluble alkali metal (e.g., potassium and preferably sodium) or ammonium salts. Preferred are 1 :4 to 4:1 copolymers of maleic anhydride or acid with another polmerizable ethylenically unsaturated monomer, preferably methylvinylether/maleic anhydride having a molecular weight (M.W.) of about 30,000 to about 1,800,000 most preferably about 30,000 to about 700,000. Examples of these copolymers are available from ISP Corporation under the tradename Gantrez, e.g., AN 139 (M.W. 500,000), AN 119 (M.W. 250,000); S-97 Pharmaceutical Grade (M.W. 700,000), AN 169 (M.W. 1,200,000-1800,000), and AN 179 (M.W. above 1,800,000); wherein the preferred copolymer is S-97 Pharmaceutical Grade (M.W. 700,000).
The anionic polycarboxylate polymer is employed in amounts effective to form the zinc-polymer-pyrophosphate complex within the oral composition. To this end, the anionic polycarboxylate polymer is incorporated in the oral care composition from about 0.1% to about 10% by weight, preferably from about 0.2% to about 3.0% by weight.
Pyrophosphate salts used to prepare the zinc/anionic polymer/pyrophosphate complexes include dialkali or tetraalkali metal pyrophosphate salts such as Na2P2O7,
KaP2O7, Na2K2P2O7, Na2H2P2O7 and K2H2P2O7. The pyrophosphate salts are included in the oral composition of the present invention at a concentration of about 1 to about 5% by weight and preferably about 0.5 to about 3% by weight.
To prepare a dentifrice composition of the present invention, the zinc salt anionic polycarboxylate polymer and pyrophosphate salt ingredients are incorporated in the oral care product which includes a vehicle which contains water, humectant, surfactant and a polishing agent.
The humectant is generally a mixture of humectants, such as glycerol, sorbitol and polyethylene glycol of molecular weight in the range of 200-1000, but other mixtures of humectants and single humectants may also be employed. The humectant content is in the range about of 10% to about 80% by weight and preferably about 30 to about 50% by weight. The water content is in the range of about 10 to about 25% by weight.
Inorganic thickeners may be included in the dentifrice component in which potassium salts are included as an ingredient include fumed silicas such as Cabosil available from Cabot Corporation, and thickening silicas including those available from Crosfield Chemicals designated Sorbosil TC-15 or Sylox 15 from W.R. Grace.
Organic thickeners of natural and synthetic gums may be incorporated in the oral care composition of the present invention. Examples of such thickeners are carrageenan (Irish moss), xanthan gum, sodium carboxymethyl cellulose, starch, polyvinylpyrrolidone, hydroxyethylpropylcellulose,hydroxybutyl methyl cellulose, hydroxypropyl methyl cellulose, and hydroxyethyl cellulose. The organic thickener may be incorporated in the compositions of the present invention at a concentration of about 0.25 to about 2% by weight and preferably about 0.5 to about 1% by weight.
Surfactants may be incorporated in the oral care product of the present invention included as an ingredient to provide foaming properties. The surfactant is preferably anionic, suitable examples of which include higher alkyl sulfates such as potassium or sodium lauryl sulfate which is preferred, higher fatty acid monoglyceride monosulfates, such as the salt of the monosulfated monoglyceride of hydrogenated coconut oil fatty acids, alkyl aryl sulfonates such as sodium dodecyl benzene sulfonate, higher fatty sulfoacetates, higher fatty acid esters of 1,2 dihydroxy propane sulfonate, and the substantially saturated higher aliphatic acyl amides of lower aliphatic amino carboxylic acid compounds, such as those having 12 to 16 carbons in the fatty acid, alkyl or acyl radicals, and the like. Examples of the last mentioned amides are N-lauroyl sarcosine, and the salts of N-lauroyl, N-myristoyl, or N-palmitoyl sarcosine. The surfactant is generally present in the oral care compositions of the present invention at a concentration of about 0.5 to about 5.0% by weight.
Abrasives may be incorporated in the oral composition of the present invention and preferred abrasives are siliceous materials, such as silica. A preferred silica is a precipitated amorphous hydrated silica, such as Sorbosil AC-35, marketed by Crosfield Chemicals, or Zeodent 115 and Zeodent 165 from Huber Company but other abrasives may also be employed, including sodium metaphosphate, potassium metaphosphate, tricalcium phosphate, calcium phosphate dihydrate, anhydrous dicalcium phosphate, calcium pyrophosphate, magnesium orthophosphate, calcium carbonate, sodium bicarbonate, alumina trihydrate, aluminum silicate, calcined alumina and bentonite. The concentration of abrasive in the oral composition of the present invention will normally be in the range of 5 to about 40% by weight and preferably 10 to 30% by weight.
Other ingredients which may be incorporated in the oral care composition of the present invention, include pigment, sweetener, flavor and preservative. In white dental cream formulations, the pigment of choice is titanium dioxide, rutile, and the proportion thereof will normally be in the range of 0.5 to 1.25% by weight, preferably 0.75 to 1 % by weight. The sweetener content will normally be that of an artificial or synthetic sweetener and the normal proportion thereof present will be in the range of 0.1 to 1% by weight, preferably 0.3 to 0.5% by weight. The flavor content, which is preferably of a mixed peppermint/menthol flavor, will usually be in the range of 0.5 to 2% by weight, preferably 0.5 to 1.5% by weight. F.D. & C Grade dyes may be used in appropriate amounts to provide desired colors. The contents of other components or adjuvants of the potassium salt containing dentifrice will normally not exceed 10% by weight, often will be less than 5% by weight, and can be as low as 0%.
To prepare the oral composition of the present invention, the zinc salt is added to a mixture of water, humectants and anionic polycarboxylate polymer and dispersed in a conventional mixer until the mixture becomes a slurry which is smooth in appearance. The pyrophosphate salt may also be added at this point, preferably predissolved as a water solution. Other water soluble ingredients such as fluoride salts and sweeteners such as sodium saccharin may also be added at this point. This mixture may be heated to 100-110°F and mixed for 10 to 30 minutes producing a homogeneous gel phase. The mixture is transferred to a vacuum mixer. The abrasive is then added and mixed for 10 to 30 minutes at high speed under a vacuum in the range of 5 to 100 millimeter of mercury pressure, preferably 5 to 50 mm Hg, providing a homogenous mixture. The surfactant and flavor are then added to the paste which is followed by mixing another 10 to 20 minutes under vacuum of 5 to 50 mm Hg. The resultant product is a stable astringent dentifrice of a texture like that of normal toothpastes or gels having a pH in the range of 5 to 8, preferably 6.5 to 7.5, e.g., 7, and of satisfactory flavor.
The following Example is further illustrative of the present invention, but it is understood that the invention is not limited thereto. All amounts referred to herein and the appended claims are by weight.
Example
An aqueous dentifrice was prepared by admixing the ingredients listed in the Table below. TABLE
Ingredient Wt.%
Deionized Water 17.54
Zinc citrate trihydrate 2.00
Gantrez S-97 (13% soln.) 11.54
PEG 600 3.00
Glycerin 11.50
Carrageenan 0.400
Sodium carboxymethyl cellulose 0.60
Sorbitol (70% soln.) 24.60
Sodium Saccharin 0.300
Tetrasodium pyrophosphate 2.0
Titanium Dioxide 1.00
Sodium fluoride 0.32
Silica 22.20
NaOH (50% soln.) 0.60
Flavor 1.20
Sodium Lauryl Sulfate 1.20
Totals 100.00
After storage of the dentifrice in sealed plastic tubes for 8 weeks at 40°F, room temperature, 105°F and 120°F, no formation of crystalline material was noted.
The astringency and palatability of the dentifrice was evaluated by a flavorist for attributes such as astringency and taste acceptability as compared to a commercial non- astringent antibacterial dentifrice which did not contain zinc ion and a commercial dentifrice known to be astringent containing 2% by weight zinc citrate.
The flavorist rated the dentifrice as having minor astringency.
By way of contrast, when the dentifrice of the Example was prepared in which the zinc citrate was incorporated in the dentifrice composition together with 1% by weight tetrasodium pyrophosphate and 7% by weight of sodium tripolyphosphate and the anionic polycarboxylate polymer Gantrez S-97 was not included in the dentifrice composition, the composition had low astringency but undesirable crystals formed in the dentifrice within 15 days when stored in plastic tubes at room temperature.

Claims

CLAIMSWhat is claimed is:
1. A stable, zinc containing aqueous oral composition having low astringency, the composition comprising an orally acceptable vehicle containing a complex formed in the vehicle from a zinc salt, an anionic polycarboxylate polymer and a pyrophosphate salt whereby less astringency is experienced by the user of the composition.
2. The composition of claim 1 wherein the zinc salt is zinc citrate.
3. The composition of claim 1 wherein the pyrophosphate salt is tetrasodium pyrophosphate or tetrapotassium pyrophosphate.
4. The composition of claim 1 wherein the anionic polycarboxylate polymer is a vinyl ether/maleic anhydride copolymer.
5. The composition of claim 1 wherein the copolymer is present in the composition at a concentration of about 0.1 to about 10% by weight.
6. The composition of claim 4 wherein the zinc salt is present in the composition at a concentration of about 1 to about 5% by weight.
7. The composition of claim 1 wherein the pyrophosphate salt is present in the composition at a concentration of about 0.5 to about 3.0% by weight.
8. A method for preparing stable, zinc containing oral composition having low astringency, which comprises preparing an orally acceptable vehicle containing water and humectants and admixing a zinc salt, an anionic polycarboxylate polymer and a pyrophosphate salt with the vehicle to form a zinc/anionic polycarboxylate/pyrophosphate complex whereby less astringency is experienced by the user of the composition.
9. The method of claim 8 wherein the zinc salt is zinc citrate.
10. The method of claim 8 wherein the pyrophosphate salt is tetrasodium pyrophosphate or tetrapotassium pyrophosphate.
11. the method of claim 8 wherein the anionic polycarboxylate polymer is a vinyl ether/maleic anhydride copolymer.
12. The method of claim 11 wherein the copolymer is present in the composition at a concentration of about 0.1 to about 10% by weight.
13. The method of claim 8 wherein the zinc salt is present in the composition at a concentration of about 1 to about 5% by weight.
14. The method of claim 8 wherein the pyrophosphate salt is present in the composition at a concentration of about 0.5 to about 3.0% by weight.
EP01992031A 2000-12-05 2001-12-04 Zinc containing dentifrice of reduced astringency Withdrawn EP1345581A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73014300A 2000-12-05 2000-12-05
US730143 2000-12-05
PCT/US2001/046895 WO2002045678A2 (en) 2000-12-05 2001-12-04 Zinc containing dentifrice of reduced astringency

Publications (1)

Publication Number Publication Date
EP1345581A2 true EP1345581A2 (en) 2003-09-24

Family

ID=24934113

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01992031A Withdrawn EP1345581A2 (en) 2000-12-05 2001-12-04 Zinc containing dentifrice of reduced astringency

Country Status (18)

Country Link
EP (1) EP1345581A2 (en)
JP (1) JP2004517833A (en)
KR (1) KR20030068166A (en)
CN (1) CN1220479C (en)
AR (1) AR031782A1 (en)
AU (1) AU2002232507A1 (en)
BR (1) BR0115949A (en)
CA (1) CA2431002A1 (en)
CZ (1) CZ20031836A3 (en)
EC (1) ECSP034678A (en)
HU (1) HUP0600590A2 (en)
MX (1) MXPA03004922A (en)
PL (1) PL361856A1 (en)
RU (1) RU2259193C2 (en)
SK (1) SK8642003A3 (en)
WO (1) WO2002045678A2 (en)
YU (1) YU44003A (en)
ZA (1) ZA200304561B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG169990A1 (en) 2005-12-21 2011-04-29 Colgate Palmolive Co Improved oral compositions comprising zinc citrate and/or tocopherol agents
US8628755B2 (en) 2007-01-30 2014-01-14 Colgate-Palmolive Company Dentifrice containing zinc ions and polyphosphate ions
CA2753671C (en) * 2009-04-02 2014-11-18 Colgate-Palmolive Company Dentifrice composition
TWI442937B (en) * 2009-05-26 2014-07-01 美國棕欖公司 Higher loading zinc-containing films
CN102596154B (en) 2009-10-29 2014-12-24 高露洁-棕榄公司 Dentifrice comprising stannous fluoride plus zinc citrate and low levels of water
TWI554286B (en) * 2010-01-29 2016-10-21 美國棕欖公司 Oral care products for sensitive enamel care (2)
SG182316A1 (en) * 2010-01-29 2012-08-30 Colgate Palmolive Co Oral care product for sensitive enamel care
CN103260704B (en) * 2010-11-04 2016-09-07 高露洁-棕榄公司 Dentifrice composition with reduced astringency
MX353686B (en) 2012-12-18 2018-01-24 Colgate Palmolive Co Stable metal ion containing compositions.
CN106456461B (en) * 2014-04-30 2020-03-06 高露洁-棕榄公司 Oral care compositions containing silica and zinc citrate
CN106255487B (en) * 2014-05-14 2020-06-16 宝洁公司 Oral care compositions with improved stability
RU2726198C2 (en) 2015-07-17 2020-07-09 Колгейт-Палмолив Компани Compositions for oral care
MX375425B (en) 2015-11-13 2025-03-06 Procter & Gamble Dentifrice compositions with improved fluoride uptake
MX383491B (en) * 2015-11-13 2025-03-14 Procter & Gamble TOOTHPASTE COMPOSITIONS WITH ANTI-TARTAR AND ANTIBACTERIAL BENEFITS.
CN117338605A (en) 2015-11-13 2024-01-05 宝洁公司 Dentifrice composition with dual fluoride source and improved fluoride uptake
MX366957B (en) 2015-11-13 2019-07-29 Procter & Gamble Dentifrice compositions with improved fluoride stability.
CN109152719A (en) * 2016-05-10 2019-01-04 高露洁-棕榄公司 Alginates dentifrice composition and preparation method thereof
CN106955244B (en) * 2017-03-03 2019-09-24 广州薇美姿实业有限公司 A kind of composition covering bad mouthfeel and its application in oral care product
GB201811065D0 (en) * 2018-07-05 2018-08-22 GlaxoSmithKline Consumer Healthcare UK IP Ltd Novel composition
BR112022017654A2 (en) 2020-03-03 2022-10-18 Unilever Ip Holdings B V AQUEOUS TOOTHPASTE GEL WITHOUT ALCOHOL
CN112315827B (en) * 2020-09-25 2023-02-28 好维股份有限公司 Oral care composition and application
JP2022100677A (en) * 2020-12-24 2022-07-06 ライオン株式会社 Dentifrice composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US5334375A (en) * 1988-12-29 1994-08-02 Colgate Palmolive Company Antibacterial antiplaque oral composition
US5000944A (en) * 1989-06-09 1991-03-19 Colgate-Palmolive Company Zinc-containing oral products with reduced astringency
HUT72042A (en) * 1992-12-18 1996-03-28 Procter & Gamble Oral compositions containing antiplaque, anticalculus agents
US6169118B1 (en) * 1998-11-12 2001-01-02 Block Drug Company, Inc. Flavor blend for masking unpleasant taste of zinc compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0245678A2 *

Also Published As

Publication number Publication date
ECSP034678A (en) 2003-08-29
SK8642003A3 (en) 2003-12-02
YU44003A (en) 2006-01-16
CN1479607A (en) 2004-03-03
HUP0600590A2 (en) 2007-01-29
AR031782A1 (en) 2003-10-01
RU2259193C2 (en) 2005-08-27
ZA200304561B (en) 2004-08-03
MXPA03004922A (en) 2003-09-10
JP2004517833A (en) 2004-06-17
RU2003120062A (en) 2005-02-10
WO2002045678A3 (en) 2003-01-16
CA2431002A1 (en) 2002-06-13
PL361856A1 (en) 2004-10-04
AU2002232507A1 (en) 2002-06-18
KR20030068166A (en) 2003-08-19
WO2002045678A2 (en) 2002-06-13
BR0115949A (en) 2003-11-04
CZ20031836A3 (en) 2003-11-12
CN1220479C (en) 2005-09-28

Similar Documents

Publication Publication Date Title
EP1345581A2 (en) Zinc containing dentifrice of reduced astringency
CA2290615C (en) Desensitizing dentifrice having limited astringency
US5730959A (en) Storage stable aqueous dentifrice compositions having improved anticalculus properties
US5578293A (en) Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy
AU691681B2 (en) Dentifrice compositions containing reactive ingredients stabilized with alkali metal compounds
US5180576A (en) Anticalculus dentifrices
US5487906A (en) Method of forming stable aqueous solutions of stannous compounds
US5932192A (en) Lower astringent two component stannous and potassium salt containing dentifrice
US5456903A (en) Method of making a tartar control baking soda dentifrice
US5885556A (en) Tartar control oral compositions
AU749805B2 (en) Dual component dentifrice composition for fluoridating teeth
WO2023049279A1 (en) Oral care compositions comprising guanidine and stannous ion source and methods
MXPA97004415A (en) Formation of stable aqueous solutions of stanno compounds
HK1026844B (en) Desensitizing dentifrice having limited astringency
MXPA99010453A (en) Desensitizing dentifrice having limited astringency

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030623

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HASSAN, MAHMOUD

Inventor name: BROWN, JAMES, R.

Inventor name: BLACKWELL, BERNIE

Inventor name: PRENCIPE, MICHAEL

Inventor name: HOIC, DIEGO, A.

17Q First examination report despatched

Effective date: 20040210

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1059219

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061012

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1059219

Country of ref document: HK